table of content
1 Introduction to Research & Analysis Reports
1.1 Antibacterial (Drug) Resistance Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Indication
1.3 Global Antibacterial (Drug) Resistance Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antibacterial (Drug) Resistance Overall Market Size
2.1 Global Antibacterial (Drug) Resistance Market Size: 2021 VS 2028
2.2 Global Antibacterial (Drug) Resistance Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Antibacterial (Drug) Resistance Sales: 2017-2028
3 Company Landscape
3.1 Top Antibacterial (Drug) Resistance Players in Global Market
3.2 Top Global Antibacterial (Drug) Resistance Companies Ranked by Revenue
3.3 Global Antibacterial (Drug) Resistance Revenue by Companies
3.4 Global Antibacterial (Drug) Resistance Sales by Companies
3.5 Global Antibacterial (Drug) Resistance Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Antibacterial (Drug) Resistance Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Antibacterial (Drug) Resistance Product Type
3.8 Tier 1, Tier 2 and Tier 3 Antibacterial (Drug) Resistance Players in Global Market
3.8.1 List of Global Tier 1 Antibacterial (Drug) Resistance Companies
3.8.2 List of Global Tier 2 and Tier 3 Antibacterial (Drug) Resistance Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Antibacterial (Drug) Resistance Market Size Markets, 2021 & 2028
4.1.2 Telavancin (Vibativ)
4.1.3 Ceftaroline Fosamil (Teflaro/ Zinforo)
4.1.4 Fidaxomicin (Dificid / Dificlir)
4.1.5 Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio)
4.1.6 Dalbavancin (Dalvance/ Xydalba)
4.1.7 Tedizolid Phosphate (Sivextro)
4.1.8 Oritavancin (Orbactiv/ Nuvocid)
4.1.9 Ceftolozane-Tazobactam (Zerbaxa)
4.1.10 Ceftazidime-Avibactam (Avycaz/ Zavicefta)
4.1.11 PHASE III DRUGS
4.2 By Type - Global Antibacterial (Drug) Resistance Revenue & Forecasts
4.2.1 By Type - Global Antibacterial (Drug) Resistance Revenue, 2017-2022
4.2.2 By Type - Global Antibacterial (Drug) Resistance Revenue, 2023-2028
4.2.3 By Type - Global Antibacterial (Drug) Resistance Revenue Market Share, 2017-2028
4.3 By Type - Global Antibacterial (Drug) Resistance Sales & Forecasts
4.3.1 By Type - Global Antibacterial (Drug) Resistance Sales, 2017-2022
4.3.2 By Type - Global Antibacterial (Drug) Resistance Sales, 2023-2028
4.3.3 By Type - Global Antibacterial (Drug) Resistance Sales Market Share, 2017-2028
4.4 By Type - Global Antibacterial (Drug) Resistance Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Indication
5.1 Overview
5.1.1 By Indication - Global Antibacterial (Drug) Resistance Market Size, 2021 & 2028
5.1.2 Complicated Urinary Tract Infection (CUTI)
5.1.3 Complicated Intra-Abdominal Infections (CIAI)
5.1.4 Blood Stream Infections (BSI)
5.1.5 Clostridium Difficile Infections (CDI)
5.1.6 Acute Bacterial Skin And Skin Structure Infections (ABSSSI)
5.1.7 Hospital Acquired Bacterial Pneumonia/Ventilator (HABP/VABP)
5.1.8 Community Acquired Bacterial Pneumonia (CABP)
5.2 By Indication - Global Antibacterial (Drug) Resistance Revenue & Forecasts
5.2.1 By Indication - Global Antibacterial (Drug) Resistance Revenue, 2017-2022
5.2.2 By Indication - Global Antibacterial (Drug) Resistance Revenue, 2023-2028
5.2.3 By Indication - Global Antibacterial (Drug) Resistance Revenue Market Share, 2017-2028
5.3 By Indication - Global Antibacterial (Drug) Resistance Sales & Forecasts
5.3.1 By Indication - Global Antibacterial (Drug) Resistance Sales, 2017-2022
5.3.2 By Indication - Global Antibacterial (Drug) Resistance Sales, 2023-2028
5.3.3 By Indication - Global Antibacterial (Drug) Resistance Sales Market Share, 2017-2028
5.4 By Indication - Global Antibacterial (Drug) Resistance Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Antibacterial (Drug) Resistance Market Size, 2021 & 2028
6.2 By Region - Global Antibacterial (Drug) Resistance Revenue & Forecasts
6.2.1 By Region - Global Antibacterial (Drug) Resistance Revenue, 2017-2022
6.2.2 By Region - Global Antibacterial (Drug) Resistance Revenue, 2023-2028
6.2.3 By Region - Global Antibacterial (Drug) Resistance Revenue Market Share, 2017-2028
6.3 By Region - Global Antibacterial (Drug) Resistance Sales & Forecasts
6.3.1 By Region - Global Antibacterial (Drug) Resistance Sales, 2017-2022
6.3.2 By Region - Global Antibacterial (Drug) Resistance Sales, 2023-2028
6.3.3 By Region - Global Antibacterial (Drug) Resistance Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Antibacterial (Drug) Resistance Revenue, 2017-2028
6.4.2 By Country - North America Antibacterial (Drug) Resistance Sales, 2017-2028
6.4.3 US Antibacterial (Drug) Resistance Market Size, 2017-2028
6.4.4 Canada Antibacterial (Drug) Resistance Market Size, 2017-2028
6.4.5 Mexico Antibacterial (Drug) Resistance Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Antibacterial (Drug) Resistance Revenue, 2017-2028
6.5.2 By Country - Europe Antibacterial (Drug) Resistance Sales, 2017-2028
6.5.3 Germany Antibacterial (Drug) Resistance Market Size, 2017-2028
6.5.4 France Antibacterial (Drug) Resistance Market Size, 2017-2028
6.5.5 U.K. Antibacterial (Drug) Resistance Market Size, 2017-2028
6.5.6 Italy Antibacterial (Drug) Resistance Market Size, 2017-2028
6.5.7 Russia Antibacterial (Drug) Resistance Market Size, 2017-2028
6.5.8 Nordic Countries Antibacterial (Drug) Resistance Market Size, 2017-2028
6.5.9 Benelux Antibacterial (Drug) Resistance Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Antibacterial (Drug) Resistance Revenue, 2017-2028
6.6.2 By Region - Asia Antibacterial (Drug) Resistance Sales, 2017-2028
6.6.3 China Antibacterial (Drug) Resistance Market Size, 2017-2028
6.6.4 Japan Antibacterial (Drug) Resistance Market Size, 2017-2028
6.6.5 South Korea Antibacterial (Drug) Resistance Market Size, 2017-2028
6.6.6 Southeast Asia Antibacterial (Drug) Resistance Market Size, 2017-2028
6.6.7 India Antibacterial (Drug) Resistance Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Antibacterial (Drug) Resistance Revenue, 2017-2028
6.7.2 By Country - South America Antibacterial (Drug) Resistance Sales, 2017-2028
6.7.3 Brazil Antibacterial (Drug) Resistance Market Size, 2017-2028
6.7.4 Argentina Antibacterial (Drug) Resistance Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Antibacterial (Drug) Resistance Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Antibacterial (Drug) Resistance Sales, 2017-2028
6.8.3 Turkey Antibacterial (Drug) Resistance Market Size, 2017-2028
6.8.4 Israel Antibacterial (Drug) Resistance Market Size, 2017-2028
6.8.5 Saudi Arabia Antibacterial (Drug) Resistance Market Size, 2017-2028
6.8.6 UAE Antibacterial (Drug) Resistance Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Melinta Therapeutics
7.1.1 Melinta Therapeutics Corporate Summary
7.1.2 Melinta Therapeutics Business Overview
7.1.3 Melinta Therapeutics Antibacterial (Drug) Resistance Major Product Offerings
7.1.4 Melinta Therapeutics Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.1.5 Melinta Therapeutics Key News
7.2 Allergan
7.2.1 Allergan Corporate Summary
7.2.2 Allergan Business Overview
7.2.3 Allergan Antibacterial (Drug) Resistance Major Product Offerings
7.2.4 Allergan Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.2.5 Allergan Key News
7.3 Merck
7.3.1 Merck Corporate Summary
7.3.2 Merck Business Overview
7.3.3 Merck Antibacterial (Drug) Resistance Major Product Offerings
7.3.4 Merck Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.3.5 Merck Key News
7.4 Abbott Laboratories
7.4.1 Abbott Laboratories Corporate Summary
7.4.2 Abbott Laboratories Business Overview
7.4.3 Abbott Laboratories Antibacterial (Drug) Resistance Major Product Offerings
7.4.4 Abbott Laboratories Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.4.5 Abbott Laboratories Key News
7.5 Pfizer
7.5.1 Pfizer Corporate Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Antibacterial (Drug) Resistance Major Product Offerings
7.5.4 Pfizer Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.5.5 Pfizer Key News
7.6 GSK
7.6.1 GSK Corporate Summary
7.6.2 GSK Business Overview
7.6.3 GSK Antibacterial (Drug) Resistance Major Product Offerings
7.6.4 GSK Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.6.5 GSK Key News
7.7 PENDOPHARM
7.7.1 PENDOPHARM Corporate Summary
7.7.2 PENDOPHARM Business Overview
7.7.3 PENDOPHARM Antibacterial (Drug) Resistance Major Product Offerings
7.7.4 PENDOPHARM Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.7.5 PENDOPHARM Key News
7.8 Absynth Biologics
7.8.1 Absynth Biologics Corporate Summary
7.8.2 Absynth Biologics Business Overview
7.8.3 Absynth Biologics Antibacterial (Drug) Resistance Major Product Offerings
7.8.4 Absynth Biologics Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.8.5 Absynth Biologics Key News
7.9 Achaogen
7.9.1 Achaogen Corporate Summary
7.9.2 Achaogen Business Overview
7.9.3 Achaogen Antibacterial (Drug) Resistance Major Product Offerings
7.9.4 Achaogen Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.9.5 Achaogen Key News
7.10 Acino Holdings
7.10.1 Acino Holdings Corporate Summary
7.10.2 Acino Holdings Business Overview
7.10.3 Acino Holdings Antibacterial (Drug) Resistance Major Product Offerings
7.10.4 Acino Holdings Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.10.5 Acino Holdings Key News
7.11 Aventis Pharma
7.11.1 Aventis Pharma Corporate Summary
7.11.2 Aventis Pharma Antibacterial (Drug) Resistance Business Overview
7.11.3 Aventis Pharma Antibacterial (Drug) Resistance Major Product Offerings
7.11.4 Aventis Pharma Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.11.5 Aventis Pharma Key News
7.12 Austell Laboratories
7.12.1 Austell Laboratories Corporate Summary
7.12.2 Austell Laboratories Antibacterial (Drug) Resistance Business Overview
7.12.3 Austell Laboratories Antibacterial (Drug) Resistance Major Product Offerings
7.12.4 Austell Laboratories Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.12.5 Austell Laboratories Key News
7.13 Assembly Biosciences
7.13.1 Assembly Biosciences Corporate Summary
7.13.2 Assembly Biosciences Antibacterial (Drug) Resistance Business Overview
7.13.3 Assembly Biosciences Antibacterial (Drug) Resistance Major Product Offerings
7.13.4 Assembly Biosciences Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.13.5 Assembly Biosciences Key News
7.14 Arpida
7.14.1 Arpida Corporate Summary
7.14.2 Arpida Business Overview
7.14.3 Arpida Antibacterial (Drug) Resistance Major Product Offerings
7.14.4 Arpida Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.14.5 Arpida Key News
7.15 Demuris
7.15.1 Demuris Corporate Summary
7.15.2 Demuris Business Overview
7.15.3 Demuris Antibacterial (Drug) Resistance Major Product Offerings
7.15.4 Demuris Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.15.5 Demuris Key News
7.16 Evolva Holding
7.16.1 Evolva Holding Corporate Summary
7.16.2 Evolva Holding Business Overview
7.16.3 Evolva Holding Antibacterial (Drug) Resistance Major Product Offerings
7.16.4 Evolva Holding Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.16.5 Evolva Holding Key News
7.17 ContraFect
7.17.1 ContraFect Corporate Summary
7.17.2 ContraFect Business Overview
7.17.3 ContraFect Antibacterial (Drug) Resistance Major Product Offerings
7.17.4 ContraFect Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.17.5 ContraFect Key News
7.18 Cerexa
7.18.1 Cerexa Corporate Summary
7.18.2 Cerexa Business Overview
7.18.3 Cerexa Antibacterial (Drug) Resistance Major Product Offerings
7.18.4 Cerexa Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.18.5 Cerexa Key News
7.19 InterMune
7.19.1 InterMune Corporate Summary
7.19.2 InterMune Business Overview
7.19.3 InterMune Antibacterial (Drug) Resistance Major Product Offerings
7.19.4 InterMune Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.19.5 InterMune Key News
7.20 Isis Pharmaceuticals
7.20.1 Isis Pharmaceuticals Corporate Summary
7.20.2 Isis Pharmaceuticals Business Overview
7.20.3 Isis Pharmaceuticals Antibacterial (Drug) Resistance Major Product Offerings
7.20.4 Isis Pharmaceuticals Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.20.5 Isis Pharmaceuticals Key News
7.21 Lyndra
7.21.1 Lyndra Corporate Summary
7.21.2 Lyndra Business Overview
7.21.3 Lyndra Antibacterial (Drug) Resistance Major Product Offerings
7.21.4 Lyndra Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.21.5 Lyndra Key News
7.22 Microbecide
7.22.1 Microbecide Corporate Summary
7.22.2 Microbecide Business Overview
7.22.3 Microbecide Antibacterial (Drug) Resistance Major Product Offerings
7.22.4 Microbecide Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.22.5 Microbecide Key News
7.23 Morphochem
7.23.1 Morphochem Corporate Summary
7.23.2 Morphochem Business Overview
7.23.3 Morphochem Antibacterial (Drug) Resistance Major Product Offerings
7.23.4 Morphochem Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.23.5 Morphochem Key News
7.24 Nabriva Therapeutics
7.24.1 Nabriva Therapeutics Corporate Summary
7.24.2 Nabriva Therapeutics Business Overview
7.24.3 Nabriva Therapeutics Antibacterial (Drug) Resistance Major Product Offerings
7.24.4 Nabriva Therapeutics Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.24.5 Nabriva Therapeutics Key News
7.25 NanoSafe Coatings
7.25.1 NanoSafe Coatings Corporate Summary
7.25.2 NanoSafe Coatings Business Overview
7.25.3 NanoSafe Coatings Antibacterial (Drug) Resistance Major Product Offerings
7.25.4 NanoSafe Coatings Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.25.5 NanoSafe Coatings Key News
7.26 Novexel
7.26.1 Novexel Corporate Summary
7.26.2 Novexel Business Overview
7.26.3 Novexel Antibacterial (Drug) Resistance Major Product Offerings
7.26.4 Novexel Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.26.5 Novexel Key News
7.27 Osel
7.27.1 Osel Corporate Summary
7.27.2 Osel Business Overview
7.27.3 Osel Antibacterial (Drug) Resistance Major Product Offerings
7.27.4 Osel Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.27.5 Osel Key News
7.28 VenatoRx Pharmaceuticals
7.28.1 VenatoRx Pharmaceuticals Corporate Summary
7.28.2 VenatoRx Pharmaceuticals Business Overview
7.28.3 VenatoRx Pharmaceuticals Antibacterial (Drug) Resistance Major Product Offerings
7.28.4 VenatoRx Pharmaceuticals Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.28.5 VenatoRx Pharmaceuticals Key News
7.29 AAIPharma Services
7.29.1 AAIPharma Services Corporate Summary
7.29.2 AAIPharma Services Business Overview
7.29.3 AAIPharma Services Antibacterial (Drug) Resistance Major Product Offerings
7.29.4 AAIPharma Services Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.29.5 AAIPharma Services Key News
7.30 ANTABIO
7.30.1 ANTABIO Corporate Summary
7.30.2 ANTABIO Business Overview
7.30.3 ANTABIO Antibacterial (Drug) Resistance Major Product Offerings
7.30.4 ANTABIO Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.30.5 ANTABIO Key News
8 Global Antibacterial (Drug) Resistance Production Capacity, Analysis
8.1 Global Antibacterial (Drug) Resistance Production Capacity, 2017-2028
8.2 Antibacterial (Drug) Resistance Production Capacity of Key Manufacturers in Global Market
8.3 Global Antibacterial (Drug) Resistance Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Antibacterial (Drug) Resistance Supply Chain Analysis
10.1 Antibacterial (Drug) Resistance Industry Value Chain
10.2 Antibacterial (Drug) Resistance Upstream Market
10.3 Antibacterial (Drug) Resistance Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Antibacterial (Drug) Resistance Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
